Valuation: Incyte Corporation

Market Cap 2.44TCr 2.12TCr 1.98TCr 1.82TCr 3.44TCr 2,32500Cr 3.48TCr 23TCr 9.12TCr 1,16200Cr 9.18TCr 8.98TCr 3,85100Cr P/E 2026 *
53.8x
P/E 2027 * 16.8x
Enterprise Value 2.02TCr 1.75TCr 1.64TCr 1.5TCr 2.84TCr 1,92100Cr 2.87TCr 19TCr 7.54TCr 96TCr 7.58TCr 7.42TCr 3,18200Cr EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.98x
Free-Float
98.13%
Yield 2026 *
-
Yield 2027 * -
1 day+1.83%
1 week-7.18%
Current month+0.90%
1 month+3.20%
3 months+24.15%
6 months+17.54%
Current year+22.10%
1 week 117
Extreme 117
126.5
1 month 110.56
Extreme 110.56
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 76.45
Extreme 76.45
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
23/07/26 Free

Chief Technology Officer

15,425 0.0077%
23/07/26 Free

EVP, Head of Incyte Intl

28,921 0.0145%
16/07/26 Free

EVP & Chief Scientific Officer

46,244 0.0231%
Change 5-day change 1-year change 3-year change Capi.($)
+1.83%-7.18%+54.54%+89.53% 2.44TCr
+0.19%+9.42%+33.09%-0.75% 7.6TCr
+1.61%-10.75%+20.93%+180.67% 4.9TCr
+3.72%-4.71%-8.40%+20.60% 4.79TCr
+1.42%+2.02%-51.10%-50.16% 4.34TCr
+3.29%+1.38%+57.68%-22.49% 3.08TCr
+3.36%+2.12%+106.19%-47.32% 2.28TCr
+4.90%+1.11%-8.15%+212.22% 1.92TCr
+0.46%-6.56%+61.68%+115.73% 1.59TCr
+2.64%-4.07%+71.87%+162.62% 1.6TCr
Average +2.20%-1.16%+33.83%+66.06% 3.45TCr
Weighted average by Cap. +1.88%+0.56%+24.38%+47.94%

Financials

2026 *2027 *
Net sales 594.25Cr 515.99Cr 481.1Cr 441.96Cr 835.85Cr 57TCr 845.03Cr 5.67TCr 2.22TCr 28TCr 2.23TCr 2.18TCr 94TCr 625.54Cr 543.15Cr 506.42Cr 465.22Cr 879.86Cr 60TCr 889.51Cr 5.97TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 99TCr
Net income 47Cr 40Cr 38Cr 35Cr 65Cr 4.43TCr 66Cr 444.4Cr 173.73Cr 2.21TCr 174.85Cr 171.02Cr 7.34TCr 147.04Cr 127.67Cr 119.04Cr 109.36Cr 206.82Cr 14TCr 209.09Cr 1.4TCr 548.64Cr 6.99TCr 552.18Cr 540.08Cr 23TCr
Net Debt -424.92Cr -368.96Cr -344.01Cr -316.02Cr -597.68Cr -40TCr -604.24Cr -4.06TCr -1.59TCr -20TCr -1.6TCr -1.56TCr -67TCr -581.22Cr -504.67Cr -470.54Cr -432.26Cr -817.52Cr -55TCr -826.49Cr -5.55TCr -2.17TCr -28TCr -2.18TCr -2.13TCr -92TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
04/26/04 $120.60 +1.83% 20,77,654
03/26/03 $118.43 -0.91% 14,19,133
31/26/31 $119.52 -2.82% 18,30,263
30/26/30 $122.99 -3.23% 26,28,292
29/26/29 $127.10 -2.18% 29,17,698
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
120.60USD
Average target price
124.96USD
Spread / Average Target
+3.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock